Adjunctive Treatment of Myxopapillary Ependymoma

Adjunctive Treatment of Myxopapillary Ependymoma Publisher

Jahanbakhshi A¹ ; Najafi M¹ ; Jafari F^{2, 3} ; Moshtaghian M^{2, 3} ; Gomar M² ; Anbarlouei M⁴ ; Naderi S⁵

Show Affiliations

1. Skull Base Research Center, Neurosurgery Department, Iran University of Medical Sciences, Tehran, Iran
2. Radiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
4. Neurosurgery Department, Baqiyatallah University of Medical Sciences, Tehran, Iran
5. Neurosurgery Department, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Oncology Reviews Published:2021

Abstract

Myxopapillary ependymoma are rare tumors and optimal therapeutic strategy is remained controversial. The main treatments for myxopapillary ependymoma tumors include surgery and radiotherapy. Hence, the present study aimed to review adjuvant treatment of myxopapillary ependymoma, focusing on spinal myxopapillary ependymoma. The information sources of all articles were the English authoritative databases including PubMed, Web of science, Scopus, Science direct and Google scholar. In this review study, the keywords including adjuvant, treatment, myxopapillary and ependymoma were selected from MeSH medical library. Related articles were published from 2000 to 2020. Given radiation tolerance in the spinal cord is 10-15% lower than that of the brain, it also should be noted that with increased dose and scope of therapeutic field, the corresponding risks are increased, as well. Also, chemotherapy has never been used as the primary treatment approach. Radiotherapy s value is considered while involving with sensitive areas where chemotherapy is also recommended. Gross total resection is the preferred primary treatment. © 2021 Page Press Publications. All rights reserved.

Style	Citing Format
MLA	Jahanbakhshi A, et al.. "Adjunctive Treatment of Myxopapillary Ependymoma." Oncology Reviews, vol. 15, no. 1, 2021, pp. -.
APA	Jahanbakhshi A, Najafi M, Jafari F, Moshtaghian M, Gomar M, Anbarlouei M, Naderi S (2021). Adjunctive Treatment of Myxopapillary Ependymoma. Oncology Reviews, 15(1), -.
Chicago	Jahanbakhshi A, Najafi M, Jafari F, Moshtaghian M, Gomar M, Anbarlouei M, Naderi S. "Adjunctive Treatment of Myxopapillary Ependymoma." Oncology Reviews 15, no. 1 (2021): -.
Harvard	Jahanbakhshi A et al. (2021) 'Adjunctive Treatment of Myxopapillary Ependymoma', Oncology Reviews, 15(1), pp. -.
Vancouver	Jahanbakhshi A, Najafi M, Jafari F, Moshtaghian M, Gomar M, Anbarlouei M, et al.. Adjunctive Treatment of Myxopapillary Ependymoma. Oncology Reviews. 2021;15(1):-.
BibTex	@article{ author = {Jahanbakhshi A and Najafi M and Jafari F and Moshtaghian M and Gomar M and Anbarlouei M and Naderi S}, title = {Adjunctive Treatment of Myxopapillary Ependymoma}, journal = {Oncology Reviews}, volume = {15}, number = {1}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Jahanbakhshi A AU - Najafi M AU - Jafari F AU - Moshtaghian M AU - Gomar M AU - Anbarlouei M AU - Naderi S TI - Adjunctive Treatment of Myxopapillary Ependymoma JO - Oncology Reviews VL - 15 IS - 1 SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract